LCM
ABBV icon

Lazari Capital Management’s AbbVie ABBV Stock Holding History

Lazari Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05M Sell
16,094
-74
-0.5% -$15.9K 1.25% 15
2026
Q1 		$3.52M Sell
16,168
-26
-0.2% -$5.77K 1.22% 16
2025
Q4 		$3.7M Buy
16,194
+2
+0% +$456 1.24% 15
2025
Q3 		$3.75M Sell
16,192
-46
-0.3% -$9.37K 1.27% 15
2025
Q2 		$3.01M Buy
16,238
+5
+0% +$929 1.13% 17
2025
Q1 		$3.4M Sell
16,233
-274
-2% -$53.3K 1.39% 13
2024
Q4 		$2.93M Sell
16,507
-901
-5% -$166K 1.17% 15
2024
Q3 		$3.44M Sell
17,408
-159
-0.9% -$29.7K 1.47% 14
2024
Q2 		$3.01M Sell
17,567
-343
-2% -$56.8K 1.36% 13
2024
Q1 		$3.26M Sell
17,910
-265
-1% -$45.7K 1.77% 11
2023
Q4 		$2.82M Sell
18,175
-187
-1% -$27.3K 1.61% 12
2023
Q3 		$2.74M Sell
18,362
-481
-3% -$70.6K 1.63% 12
2023
Q2 		$2.54M Buy
+18,843
New +$2.76M 1.43% 14

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Lazari Capital Management's ABBV Position: Q2 2026 in Review

Lazari Capital Management reduced its AbbVie (ABBV) stake by 0.46% in Q2 2026, selling an estimated $15.9K and leaving 16,094 shares worth $4.05M. The position accounts for 1.25% of the portfolio, ranked #15.

Lazari Capital Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lazari Capital Management held 16,094 shares of AbbVie worth $4.05M as of Q2 2026.
  • Lazari Capital Management sold 74 AbbVie shares in Q2 2026, an estimated $15.9K.
  • AbbVie made up 1.25% of Lazari Capital Management's portfolio in Q2 2026, its #15 holding.
  • Lazari Capital Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.